12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effect of vitamin E and ticlopidine on platelet aggregation in Fabry's disease.

      , , ,
      Clinical genetics
      Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Thromboembolism, increased platelet aggregation and high plasma concentration of beta-thromboglobulin were observed frequently in hemizygotes and heterozygotes of Fabry's disease. The administration of vitamin E and ticlopidine could improve the increased platelet aggregation in this disease. The platelet activation, probably induced by vascular endothelial damages, would accelerate atherosclerotic and thromboembolic vascular changes. Antiplatelet therapy will be effective for the prevention of these vascular complications in this disease.

          Related collections

          Author and article information

          Journal
          Clin Genet
          Clinical genetics
          Wiley
          0009-9163
          0009-9163
          May 1987
          : 31
          : 5
          Article
          10.1111/j.1399-0004.1987.tb02820.x
          2955965
          b56459b9-112b-4681-803d-72b05155f1f1
          History

          Comments

          Comment on this article